Relx (REL) PT Lowered to GBX 1,785 at Deutsche Bank
A number of other brokerages have also issued reports on REL. UBS Group reissued a sell rating on shares of Relx in a research note on Monday, September 3rd. Liberum Capital reissued a buy rating on shares of Relx in a research note on Friday, November 30th. Barclays raised Relx to an overweight rating and raised their price target for the stock from GBX 1,615 ($21.10) to GBX 1,740 ($22.74) in a research note on Monday, September 24th. Berenberg Bank reissued a buy rating and issued a GBX 1,800 ($23.52) price target on shares of Relx in a research note on Monday, October 8th. Finally, Credit Suisse Group raised their price target on Relx from GBX 1,840 ($24.04) to GBX 1,940 ($25.35) and gave the stock an outperform rating in a research note on Thursday, November 1st. One analyst has rated the stock with a sell rating, two have issued a hold rating and ten have given a buy rating to the company. The stock has a consensus rating of Buy and an average price target of GBX 1,778.08 ($23.23).
REL opened at GBX 1,621 ($21.18) on Tuesday. Relx has a twelve month low of GBX 1,399 ($18.28) and a twelve month high of GBX 1,784 ($23.31).
RELX PLC provides information and analytics for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals.
Featured Story: What is the float in trading stocks?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.